NCT06132464Completed
ECoLoGiC Speech Therapy for Everyday Communication in Aphasia
ECoLoGiC Speech Therapy Treatment: Meeting the Everyday Communication Needs of People With Aphasia Following Stroke
Source: ClinicalTrials.gov · Last updated 21 Aug 2024
Brief summary (registry, in English)
The primary goal of this clinical trial study is to evaluate the effect of a new therapy to improve talking in people with the language disability 'aphasia' after a stroke. The therapy is called: 'Expanding Communication and Language Generated in Conversation Treatment' (ECoLoGiC Treatment), and helps improve language skills for talking to other people in conversation. The second goal is to develop training materials to teach families of people with aphasia about the therapy and how to practice at home. This part of the study will be completed with help from two people with aphasia and a family member who have completed the program. The study asks: 1. How do people with aphasia improve their language skills following this therapy? Results will be determined by using tests of language and by testing language in conversation and other types of talking tasks, like describing a picture. 2. After completing the family training, do family members use the ideas they learned when talking to the person with aphasia? And, what do family members and people with aphasia think of the family training? The first question will be answered with a checklist to see if the family members followed the ideas they learned. The second question will be answered by talking with the people with aphasia and the family members to find out what they thought. The people with aphasia will complete language testing before and after therapy, and 6 weeks later (to see if improvements are maintained). Therapy is twice a week for one hour, for 10 weeks with a speech-language pathologist. During therapy, the person will have casual conversations with the speech-language pathologist, who will help the person communicate by giving small amounts of help at a time. The speech-language pathologist will tell the person what they are doing that does and does not help with communication. This process helps the person use more language and learn how to communicate better. The family members will have training with the speech-language pathologists to learn about the therapy and how to continue with the ideas at home. Training will take place over 3 sessions, scheduled in addition to therapy sessions. After therapy ends, the family members will have conversations with the person with aphasia, to show what they have learned. Each family member and person with aphasia will also have a 10-20 minute conversation with a researcher to share their thoughts about the training program.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 10 (actual)
- First submitted
- 3 Nov 2023
- Start date
- 3 Jan 2024
- Primary completion date
- 30 Jun 2024
- Lead sponsor
- University of Kansas Medical Center
- Diseases
- Stroke
- NCT number
- NCT06132464
What you commit to
- Study type: Interventional
- Participants enrolled: 10
- From 3 Jan 2024 to the primary completion date, 30 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Self-reported vision impairment preventing completion of testing (aided)
- Severe cognitive impairment as evaluated by the Cognitive Linguistic Quick Test - Plus and clinical expertise
- Neurological injury or condition other than left hemisphere stroke
- Left-handed before stroke
- Uncontrolled mental health condition
Age
- Younger than 18
- Older than 85
Other
- Unable to pass hearing screening in at least one ear at 40 decibels at 1000 Herz (aided)
- Multilingual speaker (language proficiency of greater than 4 out of 7 on reading, writing, speaking, or listening in any language other than English; self-rating bilingualism scale)
- Minimal, mild, or profound aphasia as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- No greater than a score of 2.5 on the Apraxia of Speech Rating Scale
- No greater than 3.0 on the Dysarthria-in-Interaction Profile
- Use of an alternative augmentative communication device as primary means of communication
- Spoken language production consisting of single word or no verbal communication, as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Inability to comprehend simple language in conversation, as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Inability to read single words for comprehension, as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Learning or language disability
- Unable to pass hearing screening in one ear at 40 decibels at 1000 Herz (aided)
- Cognitive status below within normal limits cut-off score as evaluated by the Montreal Cognitive Assessment
Who the study is looking for
- Age 18-85 years
- Self-reported adequate vision (aided), for testing procedures
- Pass a hearing screening (aided), in at least one ear at 40 decibels at 1000 Herz
- Monolingual speaker of English
- One or more left hemisphere stroke at least 6 months prior, leading to aphasia
- Right-handed prior to stroke
- Moderate to severe aphasia, as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Spoken language production of at least 2-3 word utterances (phrases or sentences), as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Reading comprehension of at least single words to short phrases, as evaluated by the Western Aphasia Battery - Revised and clinical expertise,
- Auditory comprehension for simple language, as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Pass a hearing screening (aided), in at least one ear at 40 decibels at 1000 Herz
- Cognitive function within normal limits as evaluated by the Montreal Cognitive Assessment
- Must speak English
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kansas University Medical Center Coordinator of this site? Confirm its status | Kansas City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.